HealthTech Start-Up Phable Bolsters Top Leadership With Two Key Appointments

Phable, India’s largest chronic disease management company has announced the appointment of Anuraag Dubey as Chief Product Officer (CPO) and SagarRamteke as Head of Corporate Development to strengthen its full-stack and value-driven chronic care ecosystem and accelerate market expansion.

With USD 25 million raised in Series B funding, Phable strives to create India’s first comprehensive healthcare ecosystem to help patients manage their condition more effectively.

According to the company, in addition to building Business-to-Consumer (B2C) and Business-to-Business (B2B) software products, Dubey brings 23 years of experience to Phable.

IIT (BHU) Varanasi alumnus, who has previously built and grown adoption of India-focused B2C and Software as a Service (SaaS) products in Education and Healthcare, has worked for companies such as Edureka and Practo prior to joining Phable.

Dubey will play a crucial role in developing the company’s product and tech aligned with its mission to simplify chronic disease management through the Phable App, so that more consumers will take up active management of conditions like Sugar and BP. Working closely with the Phable co-founders and executive leadership team, he will play a vital role in the company’s success.

Sumit Sinha andMukesh Bansal, Co-Founders of Phable in a joint statement said, “As we continue to grow towards our mission of helping chronic disease patients to manage their ailment at lower costs and stay out of a hospital for as long as possible, Dubey and Ramteke’s extensive experience will be an immense asset to the company. Our objective is to maximise our services full-scale to impact 1.6 billion lives, and by bringing industry veterans likeDubey and Ramteke on board, we aim to expedite that process.”

An alumnus of Institute of Life Science (ILS), Pune, Ramteke is an accomplished business leader with more than two decades of experience in technology, business operations, strategic sourcing, sales, investments, and fundraising.

Having worked in international markets such as Europe, America, China, and India, he has diverse geographical and cultural experience. He will report to Sumit Sinha who is also CEO of the company, and will oversee Mergers and Acquisitions (M&A), fund raising, and strategic investments related activities in Phable.

A Bengaluru-based healthtech start-up, Phable offers a unique two-sided platform to treat chronic illnesses and connect patients and doctors to help drive better outcomes in chronic disease management. The platform enables digital prescriptions, personalised health reminders, and vitals tracking by syncing with devices from daily steps to blood levels. The market leader in this segment, the company caters to more than 30 lakh patients and over 10,000 doctors since it was founded in 2018.

The platform operates in the chronic care management space in India, and has a full-stack and two-sided technology for both patients and doctors that allows to drive revolutionary patient care access and experience.

Using a unique full-stack solution, the platform bridges the gap between doctors and patients to deliver remote consultations and care, timely and intelligent insights, and simplified access to healthcare essentials.

Phable also has the world’s largest ecosystem of connected devices that uses health signals to improve health outcomes and lower healthcare costs. It has built an ecosystem of care providers, hospitals, medical device manufacturers, health and wellness product manufacturers, e-pharmacy retailers, and insurance partners to bring digital healthcare to millions of Indians.

Phable helps doctors extend their practice beyond geographical boundaries and build better relationships with patients.